A reduction of the fasting period may prevent or reduce the rise in plasma Phe concentration. Therefore, the aim of the study is to measure the effect of the application of slow releasing carbohydrates (SRC) as evening meal before bedtime on the…
ID
Source
Brief title
Condition
- Protein and amino acid metabolism disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Differences in blood Phe concentrations (and other amino acids?) between early
morning (A) and end of the day (B) in the two study periods under the
different conditions (without intervention, with SRC and with SRC) will be
compared.
Secondary outcome
Relationship between the severity of the disease defined as the individual Phe
tolerance at 5 years of age, and the resulting mean and SD of blood Phe
concentrations of each period will be tested with univariate linear regression
analysis (ANOVA).
Background summary
Metabolic control in PKU is based on regular blood sampling to measure plasma
Phe concentration. The intake of Phe is adjusted when plasma Phe concentrations
are not within the target range, taking into account other factors that
influence metabolic control: e.g. intercurrent infections, growth, energy
intake and amino acid supplementation. Studies on the diurnal variation of
plasma Phe concentrations, showed an inverse pattern when compared with
healthy controls: in PKU patients Phe concentrations measured after an
overnight fast are the highest, and decrease during the day. A hypothesis for
the rise in blood Phe concentration overnight is the occurrence of catabolism
during the fasting period resulting in a higher amount of Phe available than
the amount used for protein synthesis.
Study objective
A reduction of the fasting period may prevent or reduce the rise in plasma Phe
concentration. Therefore, the aim of the study is to measure the effect of the
application of slow releasing carbohydrates (SRC) as evening meal before
bedtime on the overnight fasting blood Phe concentration in comparison to fast
releasing carbohydrates (FRC).
Study design
This pilot study has a randomized double-blind cross-over design
Intervention
Addition of SRC or FRC to the 3d portion of amino-acid supplementation at
bedtime: the additional carbohydrates will be diluted in the fluid amino acid
supplement with some extra water. When the amino acid supplement is not taken
as a fluid, the additional carbohydrates will be solved in water and (optional)
flavouring (flavor sachets Vitaflo).
Study burden and risks
Extra risico's ten opzichte van de gebruikelijke behandeling worden bij de
studie niet verwacht. De extra inname van koolhydraten kan de uitgesproken
smaak van de gebruikelijke aminozuren wel enigszins beinvloeden en zal ook het
volume van deze suppletie vergroten, maar de verwachting is dat dit geen grote
problemen zal geven.
Participating the study includes during 2 periods of 8 days:
- twice daily a fingerpuncture, daily report of stool and body weight
- during 2 of the 8-days period food record registration
- taking the individual diet as usual for the patient with exception of the
third portion amino acid supplementation, to which ad bedtime in the
intervention period slow and fast releasing carbohydrates will be added conform
the study protocol.
The study will be performed at home, and the extra effort of the participants
concerns mainly the higher frequency of bloodsampling with a fingerpuncture.
Risks associated with the study are not to be expected. May be the extra intake
of carbohydrates will influence the taste and volume of the amino acid mixture
but is not expected as problematic as the mixture itself has a very pronounced
taste.
Postbus 30.001
9700 RB Groningen
Nederland
Postbus 30.001
9700 RB Groningen
Nederland
Listed location countries
Age
Inclusion criteria
They are in good metabolic control, defined as a blood Phe concentration measurement within the target range of 120-360 µmol/l (Dutch PKU Advice Committee) one month prior to the study period. Apart from the PKU the patients are in a healthy state during the study periods. Their growth figures are within +/- 2 SD of the national growth charts. Patients take their amino acid supplementation divided into three portions each day. Participants / parents or caretakers are capable of routinely home skin puncturing without problems.
Exclusion criteria
Blood Phe concentrations frequently beyond the target range, bad compliance in intake of the amino acid mixture, growth retardation > -2SD, obesity > +2SD, insufficient knowledge of the Dutch language of the caretaker, not taking blood samples at home
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL18797.042.07 |